Metagenomi Therapeutics (MGX) Interest & Investment Income (2023 - 2026)
Metagenomi Therapeutics (MGX) reported Interest & Investment Income of $1.5 million for Q1 2026, down 46.69% year-over-year from $2.9 million in Q1 2025, and down 18.31% quarter-over-quarter from $1.9 million in Q4 2025.
Metagenomi Therapeutics (MGX) Interest & Investment Income (2023 - 2026) Analysis & Trends
Metagenomi Therapeutics (MGX) has 4 years of Interest & Investment Income data on file, last reported at $1.5 million in Q1 2026.
- Interest & Investment Income for Q1 2026 came in at $1.5 million, down 46.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (down 40.61% YoY), and the FY2025 annual result was $9.5 million, down 35.67% from the prior year.
- Interest & Investment Income fell to $1.5 million in Q1 2026 per MGX's latest filing, from $1.9 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $4.0 million in Q1 2023 and troughed at $1.5 million in Q1 2026.
- A 4-year average of $3.2 million and a median of $3.6 million in 2024 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2024 and 2026: Interest & Investment Income grew 0.23% in 2024, then tumbled 46.69% in 2026.
- A 4-year view of Interest & Investment Income shows it stood at $3.6 million in 2023, then slipped by 12.0% to $3.2 million in 2024, then plunged by 41.05% to $1.9 million in 2025, then slipped by 18.31% to $1.5 million in 2026.
- Business Quant data shows MGX's Interest & Investment Income at $1.5 million in Q1 2026, $1.9 million in Q4 2025, and $2.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | 597,319.59 |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | 305,000.00 |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | -14.79 Mn |
| 10 | Metagenomi Therapeutics | 46.60 Mn | 46.60 Mn | - | 1.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.54 Mn |
| Dec 31, 2025 | 1.88 Mn |
| Sep 30, 2025 | 2.21 Mn |
| Jun 30, 2025 | 2.49 Mn |
| Mar 31, 2025 | 2.89 Mn |
| Dec 31, 2024 | 3.20 Mn |
| Sep 30, 2024 | 3.62 Mn |
| Jun 30, 2024 | 3.98 Mn |
| Mar 31, 2024 | 3.93 Mn |
| Dec 31, 2023 | 3.63 Mn |
| Sep 30, 2023 | 3.87 Mn |
| Jun 30, 2023 | 3.97 Mn |
| Mar 31, 2023 | 4.00 Mn |